Could we design the RCT as a non-inferiority trial at this situation? [Design Issues]

posted by dennis001 – Hong Kong, 2022-07-27 07:21 (1030 d 14:53 ago) – Posting: # 23181
Views: 3,922

Dear ElMaestro
Thanks!

❝ Clearly a case for an NI trial one way or another.


Thank you for your comment that helped to assuage my doubts.

❝ Clearly a case for a scientific advice where you need the authority's nod for margin and design before you kick off.


Ok. we will discuss with them.

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,680 registered users;
56 visitors (0 registered, 56 guests [including 13 identified bots]).
Forum time: 22:15 CEST (Europe/Vienna)

Being really good at C++ is like being really good
at using rocks to sharpen sticks.    Thant Tessman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5